WINDLAS BIOTECH
Back to Income Statement
|
WINDLAS BIOTECH Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹631 Cr | ₹513 Cr | ₹466 Cr | ₹428 Cr | ₹329 Cr |
What is the latest Revenue of WINDLAS BIOTECH ?
Year | Revenue |
---|---|
Mar2024 | ₹631 Cr |
Mar2023 | ₹513 Cr |
Mar2022 | ₹466 Cr |
Mar2021 | ₹428 Cr |
Mar2020 | ₹329 Cr |
How is Revenue of WINDLAS BIOTECH Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹631 Cr | 22.97 | |
Mar2023 | ₹513 Cr | 10.12 | |
Mar2022 | ₹466 Cr | 8.96 | |
Mar2021 | ₹428 Cr | 30.03 | |
Mar2020 | ₹329 Cr | - |
Compare Revenue of peers of WINDLAS BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WINDLAS BIOTECH | ₹1,874.3 Cr | -12.4% | -3.5% | 67% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹396,394.0 Cr | -6.7% | 2.6% | 5% | Stock Analytics | |
DIVIS LABORATORIES | ₹142,920.0 Cr | -6.6% | -3.7% | 43.8% | Stock Analytics | |
CIPLA | ₹114,383.0 Cr | -5.3% | -2.9% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,817.0 Cr | -3.8% | 1.8% | 25.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹91,385.4 Cr | -4.9% | -3.3% | -10.2% | Stock Analytics |
WINDLAS BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WINDLAS BIOTECH | -12.4% |
-3.5% |
67% |
SENSEX | -3.6% |
-0.7% |
-0.5% |
You may also like the below Video Courses